Clinical significance of PD-L1 expression in both cancer and stroma cells of cholangiocarcinoma patients

Y Kitano, Y Yamashita, Y Nakao, R Itoyama… - Annals of Surgical …, 2020 - Springer
Background The clinical significance of programmed death 1 and its ligand (PD-L1) as
therapeutic targets has been reported previously. This study aimed to investigate the clinical …
被引用次数：39 相关文章

Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients

K Yuki, Y Yo-ichi, N Yosuke, I Rumi… - Annals of Surgical …, 2020 - search.proquest.com
Background The clinical significance of programmed death 1 and its ligand (PD-L1) as
therapeutic targets has been reported previously. This study aimed to investigate the clinical …

[引用][C] Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients

Y Kitano, Y Yamashita, Y Nakao, R Itoyama… - Annals of Surgical …, 2019 - cir.nii.ac.jp
Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of
Cholangiocarcinoma Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients

Y Kitano, YI Yamashita, Y Nakao… - Annals of surgical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The clinical significance of programmed death 1 and its ligand (PD-L1) as
therapeutic targets has been reported previously. This study aimed to investigate the clinical …

Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients.

Y Kitano, YI Yamashita, Y Nakao, R Itoyama… - Annals of Surgical …, 2019 - europepmc.org
Background The clinical significance of programmed death 1 and its ligand (PD-L1) as
therapeutic targets has been reported previously. This study aimed to investigate the clinical …